WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Wednesday.
The Centers for Medicare & Medicaid Services (CMS) is increasing the Medicare payment amount for administering the COVID-19 vaccine. This new and higher payment rate will support important actions taken by providers that are designed to increase the number of vaccines they can furnish each day, including establishing new or growing existing vaccination sites, conducting patient outreach and education, and hiring additional staff.
Right before Christmas The Commonwealth Fund in New York City issued a worrisome report aimed particularly at the 38 million beneficiaries who are in the so-called traditional Medicare fee-for-service program, not the heavily advertised Medicare Advantage managed care plans. The Fund* explained that the Center for Medicare & Medicaid Services (CMS) had just unveiled the Geographic Contracting model, or “Geo,” a wonky proposal meaning that beneficiaries in traditional Medicare in 10 metro regions across the country,
On December 1, 2020, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that includes updates on policy changes for Medicare payments under the Physician Fee Schedule (PFS), and other Medicare Part B issues, on or after January 1, 2021.
The Trump Administration and Centers for Medicare & Medicaid Services (CMS) are delivering on their commitment to foster innovation in Medicaid by providing states with new tools to help beneficiaries return home from institutional settings without sacrificing safety or quality of care.